Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules

Keyphrases

• Scintigraphy 100%
• Solitary Pulmonary Nodule 100%
• Tc-99m Depreotide 100%
• Tumor Uptake 66%
• Tumor 50%
• Technetium 50%
• Negative Predictive Value 33%
• Computed Tomography 33%
• Tumor-to-background Ratio 33%
• Computed Tomographic 33%
• Positive Predictive Value 16%
• Intravenous Injection 16%
• Consecutive Patients 16%
• Region of Interest 16%
• Malignancy 16%
• Histology 16%
• Imaging Modalities 16%
• Positron Emission Tomography 16%
• Technetium-99m 16%
• True Positive 16%
• Somatostatin Receptor 2 (SSTR2) 16%
• SSTR3 16%
• Somatostatin Receptor 16%
• True Negative 16%
• Lung Tumor 16%
• Acute Inflammation 16%
• Somatostatin Receptor 5 16%
• Active Inflammation 16%
• Tumor Differentiation 16%
• Sensitive Imaging 16%
• Pathological Correlation 16%
• Single Pulmonary Nodule 16%
• Whole-body Imaging 16%
• Tumor Histology 16%
• Peptide Analogs 16%
• Single Photon Emission Computed 16%
• Imaging Agents 16%
• Tomographic Studies 16%
• Depreotide 16%
• Specific Imaging 16%

Medicine and Dentistry

• Neoplasm 100%
• Scintigraphy 100%
• Lung Nodule 100%
• Depreotide Tc 99m 100%
• Computer Assisted Tomography 22%
• Receptor 22%
• Biopsy Technique 22%
• Intravenous Drug Administration 11%
• False Positive Result 11%
• Cancer 11%
• Histopathology 11%
• Technetium-99 11%
• False Negative Result 11%
• Positron Emission Tomography 11%
• Somatostatin Receptor 11%
• Lung Tumor 11%
• Somatostatin Receptor 3 11%
• Imaging Agent 11%
• Somatostatin Receptor 2 11%
• Whole Body Imaging 11%
• Depreotide 11%
• Somatostatin Receptor 5 11%